• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯巴比妥对大鼠体内模型非微粒体酶可代谢磺胺类药物的分布药代动力学及生物半衰期的影响。

Effects of phenobarbital on the distribution pharmacokinetics and biological half-lives of model nonmicrosomal enzyme metabolizable sulfonamides in rats.

作者信息

Nagwekar J B, Kundu S

出版信息

J Pharm Sci. 1982 Apr;71(4):422-6. doi: 10.1002/jps.2600710412.

DOI:10.1002/jps.2600710412
PMID:7086650
Abstract

The pharmacokinetics of sulfisoxazole and sulfanilamide were studied in control rats and in rats treated for 5 days with a daily 100 mg/kg ip dose of phenobarbital. These drugs represent the organic anionic and nonionized drugs, respectively, whose nonmicrosomal enzymatic metabolisms were unstimulated by phenobarbital. Sulfisoxazole showed the characteristics of a two-compartment open model. However, its biological half-life and the apparent distribution volume of the central compartment were significantly lower and the intercompartmental transport rate constants and the urinary excretion rate constant were significantly greater, in phenobarbital treated rats than in control rats. The apparent steady-state distribution volume of sulfisoxazole was smaller in the phenobarbital treated rats at the 90% confidence level. Sulfanilamide showed characteristics of a one-compartment model in both the control and phenobarbital treated rats, but none of the pharmacokinetic parameters of the compound in the phenobarbital treated rats were significantly different from those in the control rats.

摘要

在对照大鼠以及用苯巴比妥以每日100mg/kg腹腔注射剂量处理5天的大鼠中研究了磺胺异恶唑和磺胺的药代动力学。这些药物分别代表有机阴离子药物和非离子化药物,其非微粒体酶代谢不受苯巴比妥刺激。磺胺异恶唑呈现双室开放模型的特征。然而,在苯巴比妥处理的大鼠中,其生物半衰期和中央室的表观分布容积显著更低,而室间转运速率常数和尿排泄速率常数显著更高,与对照大鼠相比。在90%置信水平下,苯巴比妥处理的大鼠中磺胺异恶唑的表观稳态分布容积更小。磺胺在对照大鼠和苯巴比妥处理的大鼠中均呈现一室模型的特征,但苯巴比妥处理的大鼠中该化合物的药代动力学参数与对照大鼠相比均无显著差异。

相似文献

1
Effects of phenobarbital on the distribution pharmacokinetics and biological half-lives of model nonmicrosomal enzyme metabolizable sulfonamides in rats.苯巴比妥对大鼠体内模型非微粒体酶可代谢磺胺类药物的分布药代动力学及生物半衰期的影响。
J Pharm Sci. 1982 Apr;71(4):422-6. doi: 10.1002/jps.2600710412.
2
Effects of phenobarbital on the distribution pharmacokinetics and biological half-lives of model nonmetabolizable organic anions in rats.苯巴比妥对大鼠体内模型性非代谢有机阴离子分布药代动力学及生物半衰期的影响。
J Pharm Sci. 1982 Mar;71(3):275-81. doi: 10.1002/jps.2600710303.
3
Segmental difference and effect of glucose on drug exsorption across the small intestine of rats.葡萄糖对大鼠小肠药物外排的节段性差异及影响
J Pharm Sci. 1985 Mar;74(3):316-20. doi: 10.1002/jps.2600740319.
4
[Kinetics, elimination and transport of acetyl-gantrisine (acetyl-sulfisoxazole). II].[乙酰甘氨酰胺(乙酰磺胺异恶唑)的动力学、消除及转运。II]
Clin Chim Acta. 1957 Dec;2(6):548-59. doi: 10.1016/0009-8981(57)90060-8.
5
Relationship between protein binding of bilirubin, salicylic acid, and sulfisoxazole in serum of unmedicated and phenobarbital-treated rats.未用药及苯巴比妥处理的大鼠血清中胆红素、水杨酸和磺胺异恶唑的蛋白结合关系。
J Pharm Sci. 1977 Jul;66(7):1025-7. doi: 10.1002/jps.2600660733.
6
[Study of the kinetics, elimination & transit of gantrisin (3,4-dimethyl-5-sulfanilamido-isoazole). I].[甘特里辛(3,4-二甲基-5-磺胺异恶唑)的动力学、消除及转运研究。I]
Clin Chim Acta. 1957 Oct;2(5):429-41. doi: 10.1016/0009-8981(57)90040-2.
7
Effects of phenobarbital steady state levels on antipyrine clearance and distribution in the rat.
Biopharm Drug Dispos. 1986 Jan-Feb;7(1):11-9. doi: 10.1002/bdd.2510070103.
8
Effect of serum protein binding on sulfisoxazole distribution, metabolism, and excretion in rats.血清蛋白结合对大鼠体内磺胺异恶唑分布、代谢及排泄的影响。
J Pharm Sci. 1979 Jun;68(6):742-6. doi: 10.1002/jps.2600680624.
9
Studies on absorption of drugs. VI. Effects of buffer components on the absorption of drugs.药物吸收的研究。VI. 缓冲成分对药物吸收的影响。
Chem Pharm Bull (Tokyo). 1971 Sep;19(9):1925-8. doi: 10.1248/cpb.19.1925.
10
[Behavior of sulfanilamides in the body].
Arzneimittelforschung. 1970 Sep;20(9):1171-9.